{"transactions":[{"id":938328,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T16:15:31.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":20385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,385 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."}],"balance_after":394150,"source":{"system":"sec-edgar","filing":"0001493152-26-002425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315226002425/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-14"}},{"id":939089,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-14T20:51:39.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":20385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,385 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":394150,"source":{"system":"sec-edgar","filing":"0001493152-26-002298","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315226002298/ownership.xml","form_type":"4"}},{"id":957016,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-30T16:30:27.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":156250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":518774,"derivative":{"exercise_price":1.2,"expiration_date":"2035-12-29","underlying":"Class A Common Stock","underlying_shares":156250},"source":{"system":"sec-edgar","filing":"0001493152-25-029614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225029614/ownership.xml","form_type":"4"}},{"id":957015,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-30T16:30:27.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":373765,"source":{"system":"sec-edgar","filing":"0001493152-25-029614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225029614/ownership.xml","form_type":"4"}},{"id":960666,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-22T16:30:18.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025."}],"balance_after":248765,"source":{"system":"sec-edgar","filing":"0001493152-25-028778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225028778/ownership.xml","form_type":"4"}},{"id":991078,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-21T16:15:24.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":47042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the date of grant."}],"balance_after":248765,"source":{"system":"sec-edgar","filing":"0001493152-25-024630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225024630/ownership.xml","form_type":"4"}},{"id":1235294,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-03T16:30:19.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":84746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":416459,"derivative":{"exercise_price":2.225,"expiration_date":"2034-12-19","underlying":"Class A Common Stock","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001493152-25-008871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225008871/ownership.xml","form_type":"4/A","original_submission_date":"2025-01-06"}},{"id":1235293,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-03-03T16:30:19.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67,416 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":201723,"source":{"system":"sec-edgar","filing":"0001493152-25-008871","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225008871/ownership.xml","form_type":"4/A","original_submission_date":"2025-01-06"}},{"id":1309800,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-06T16:54:29.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":84746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":362524,"derivative":{"exercise_price":2.225,"expiration_date":"2034-12-19","underlying":"Class A Common Stock","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001493152-25-001035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225001035/ownership.xml","form_type":"4"}},{"id":1309799,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-06T16:54:29.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67,416 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":1374482,"source":{"system":"sec-edgar","filing":"0001493152-25-001035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000149315225001035/ownership.xml","form_type":"4"}},{"id":1844348,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2023-06-26T18:32:15.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":132352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These options were automatically granted following the Issuer's annual shareholders meeting pursuant to a policy adopted by the Issuer's board of directors providing for annual non-employee director compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest on the earliest of (i) the one-year anniversary of the grant date, (ii) the following year's annual stockholder meeting, and (iii) a Change in Control (as defined in the Vaxxinity, Inc. 2021 Omnibus Incentive Compensation Plan), in each case, subject to the Reporting Person's continued service with the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates."}],"balance_after":132352,"derivative":{"exercise_price":2.21,"underlying":"Class A common stock","underlying_shares":132352},"source":{"system":"sec-edgar","filing":"0001437749-23-018535","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774923018535/rdgdoc.xml","form_type":"4"}},{"id":1851534,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:48:59.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":277778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":277778,"derivative":{"exercise_price":0.7503,"expiration_date":"2033-06-14","underlying":"Class A Common Stock","underlying_shares":277778},"source":{"system":"sec-edgar","filing":"0000899243-23-015863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000089924323015863/doc4.xml","form_type":"4"}},{"id":1851533,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-16T20:48:59.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":199921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock.  The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 199,921 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock.  The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":1307066,"source":{"system":"sec-edgar","filing":"0000899243-23-015863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000089924323015863/doc4.xml","form_type":"4"}},{"id":1908483,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2023-05-02T10:46:25.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":false,"shares":46500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are subject to a four-year vesting schedule, beginning on June 2, 2020, vesting in equal installments each month during the vesting period."}],"balance_after":732642,"derivative":{"exercise_price":1.21,"expiration_date":"2031-03-01","underlying":"Class A common stock","underlying_shares":46500},"source":{"system":"sec-edgar","filing":"0001437749-23-012008","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774923012008/rdgdoc.xml","form_type":"4"}},{"id":1908482,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2023-05-02T10:46:25.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":false,"shares":429037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are subject to a four-year vesting schedule, with 25% having vested on December 30, 2020 and the remainder vesting in thirty-six equal installments each month during the remainder of the vesting period"}],"balance_after":99009,"derivative":{"exercise_price":0.57,"expiration_date":"2031-03-01","underlying":"Class A common stock","underlying_shares":429037},"source":{"system":"sec-edgar","filing":"0001437749-23-012008","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774923012008/rdgdoc.xml","form_type":"4"}},{"id":1908481,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true}}],"security":"Class A common stock","published_at":"2023-05-02T10:46:25.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":true,"shares":46500,"price":1.21,"value":56265.0,"ownership":{"direct":true},"balance_after":906141,"source":{"system":"sec-edgar","filing":"0001437749-23-012008","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774923012008/rdgdoc.xml","form_type":"4"}},{"id":1908480,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true}}],"security":"Class A common stock","published_at":"2023-05-02T10:46:25.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":true,"shares":429037,"price":0.57,"value":244551.09,"ownership":{"direct":true},"balance_after":859641,"source":{"system":"sec-edgar","filing":"0001437749-23-012008","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774923012008/rdgdoc.xml","form_type":"4"}},{"id":2015321,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-14T19:24:13.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":1071000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":2660136,"derivative":{"exercise_price":0.28,"expiration_date":"2027-06-02","underlying":"Class A Common Stock","underlying_shares":1071000},"source":{"system":"sec-edgar","filing":"0000899243-23-005063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000089924323005063/doc4.xml","form_type":"4"}},{"id":2015320,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-14T19:24:13.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":1071000,"price":0.28,"value":299880.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 36,145 shares underlying restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":1107145,"source":{"system":"sec-edgar","filing":"0000899243-23-005063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000089924323005063/doc4.xml","form_type":"4"}},{"id":2190516,"issuer":{"id":124742,"kind":"organization","name":"DPCM Capital, Inc.","symbol":"XPOA"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2022-08-09T16:31:22.000Z","date":"2022-08-05","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As describd in the DPCM Capital, Inc.'s registration statement on Form S-1 (File No. 333-249274) under the heading \"Description of Securities,\" the Class B Common Stock of the issuer automatically converts into Class A Common Stock of the issuer (\"Class A Common Stock\") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(Continued from Footnote 1) On August 5, 2022, the issuer consummated its initial business combination (the \"Business Combination\") with D-Wave Quantum, Inc. (\"Newco\"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As describd in the DPCM Capital, Inc.'s registration statement on Form S-1 (File No. 333-249274) under the heading \"Description of Securities,\" the Class B Common Stock of the issuer automatically converts into Class A Common Stock of the issuer (\"Class A Common Stock\") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from Footnote 1) On August 5, 2022, the issuer consummated its initial business combination (the \"Business Combination\") with D-Wave Quantum, Inc. (\"Newco\"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As describd in the DPCM Capital, Inc.'s registration statement on Form S-1 (File No. 333-249274) under the heading \"Description of Securities,\" the Class B Common Stock of the issuer automatically converts into Class A Common Stock of the issuer (\"Class A Common Stock\") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(Continued from Footnote 1) On August 5, 2022, the issuer consummated its initial business combination (the \"Business Combination\") with D-Wave Quantum, Inc. (\"Newco\"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-22-028097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000089924322028097/doc4.xml","form_type":"4"}},{"id":2190515,"issuer":{"id":124742,"kind":"organization","name":"DPCM Capital, Inc.","symbol":"XPOA"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-08-09T16:31:22.000Z","date":"2022-08-05","kind":"other","acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the Business Combination, the Reporting Person exchanged its shares of Class A Common Stock for 45,000 fully paid and non-assessable shares of common stock, par value U.S. $0.0001 per share of Newco."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-028097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000089924322028097/doc4.xml","form_type":"4"}},{"id":2190514,"issuer":{"id":124742,"kind":"organization","name":"DPCM Capital, Inc.","symbol":"XPOA"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-08-09T16:31:22.000Z","date":"2022-08-05","kind":"exercise","acquired":true,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As describd in the DPCM Capital, Inc.'s registration statement on Form S-1 (File No. 333-249274) under the heading \"Description of Securities,\" the Class B Common Stock of the issuer automatically converts into Class A Common Stock of the issuer (\"Class A Common Stock\") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) On August 5, 2022, the issuer consummated its initial business combination (the \"Business Combination\") with D-Wave Quantum, Inc. (\"Newco\"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock."}],"balance_after":45000,"source":{"system":"sec-edgar","filing":"0000899243-22-028097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000089924322028097/doc4.xml","form_type":"4"}},{"id":2206812,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T21:21:41.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":54152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":54152,"derivative":{"exercise_price":4.15,"expiration_date":"2032-07-13","underlying":"Class A Common Stock","underlying_shares":54152},"source":{"system":"sec-edgar","filing":"0000899243-22-026206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000089924322026206/doc4.xml","form_type":"4"}},{"id":2206811,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-07-15T21:21:41.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":36145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock.  The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":36145,"source":{"system":"sec-edgar","filing":"0000899243-22-026206","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000089924322026206/doc4.xml","form_type":"4"}},{"id":2223159,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2022-06-23T19:58:27.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":129187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These options were automatically granted following the Issuer's annual shareholders meeting pursuant to a policy adopted by the Issuer's board of directors providing for annual non-employee director compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest on the earliest of (i) the one-year anniversary of the grant date, (ii) the following year's annual stockholder meeting, and (iii) a Change in Control (as defined in the Vaxxinity, Inc. 2021 Omnibus Incentive Compensation Plan), in each case, subject to the Reporting Person's continued service with the issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates."}],"balance_after":129187,"derivative":{"exercise_price":2.09,"underlying":"Class A common stock","underlying_shares":129187},"source":{"system":"sec-edgar","filing":"0001437749-22-015780","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922015780/rdgdoc.xml","form_type":"4"}},{"id":2223155,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true}}],"security":"Class A common stock","published_at":"2022-06-23T19:49:42.000Z","date":"2022-01-24","kind":"tax_withholding","acquired":false,"shares":312659,"price":8.6,"value":2688867.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person unintentionally omitted this transaction from the Form 4 filed on January 26, 2022. These disposed shares were cancelled as part of a cashless exercise of stock options."}],"balance_after":430604,"source":{"system":"sec-edgar","filing":"0001437749-22-015775","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922015775/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-01-26"}},{"id":2223154,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true}}],"security":"Class A common stock","published_at":"2022-06-23T19:47:59.000Z","date":"2021-11-18","kind":"sale","acquired":false,"shares":248,"price":13,"value":3224.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In the Form 4 filed on November 18, 2021, the Reporting Person omitted this sale of stock to cover fees in connection with the previously reported transaction."}],"balance_after":90499,"source":{"system":"sec-edgar","filing":"0001437749-22-015774","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922015774/rdgdoc.xml","form_type":"4/A","original_submission_date":"2021-11-18"}},{"id":2223153,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true}}],"security":"Series A preferred stock","published_at":"2022-06-23T19:44:40.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":21511,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person unintentionally omitted this transaction from the Form 4 filed on November 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":13824},"source":{"system":"sec-edgar","filing":"0001437749-22-015773","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922015773/rdgdoc.xml","form_type":"4/A","original_submission_date":"2021-11-15"}},{"id":2223152,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true}}],"security":"Class A common stock","published_at":"2022-06-23T19:44:40.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":13824,"ownership":{"direct":false,"nature":"Held by spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person incorrectly reported that 271,655 shares of Class A common stock were acquired by the Reporting Person's spouse upon the conversion of Series A preferred stock. Instead, 13,824 shares of Class A common stock were acquired by the Reporting Person's spouse upon the conversion of Series A preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held by Kristin Diamandis, the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Kristin Diamandis in which the Reporting Person has no pecuniary interest."}],"balance_after":13824,"source":{"system":"sec-edgar","filing":"0001437749-22-015773","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922015773/rdgdoc.xml","form_type":"4/A","original_submission_date":"2021-11-15"}},{"id":2223151,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true}}],"security":"Class A common stock","published_at":"2022-06-23T19:44:40.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":13824,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person unintentionally omitted this transaction from the Form 4 filed on November 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."}],"balance_after":13824,"source":{"system":"sec-edgar","filing":"0001437749-22-015773","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922015773/rdgdoc.xml","form_type":"4/A","original_submission_date":"2021-11-15"}},{"id":2425323,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-26T18:39:45.000Z","date":"2022-01-24","kind":"exercise","acquired":false,"shares":652764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person held 815,955 of these stock options set to expire on 1/26/2022 at the time of the transaction. 80% of the stock options vested upon closing of the initial public offering, and the remaining 20% are expected to expire before meeting vesting conditions. Previously, these stock options were incorrectly reported as having an expiration date of the earlier of one year following vesting and 8/3/2031."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Reporting Person held 815,955 of these stock options set to expire on 1/26/2022 at the time of the transaction. 80% of the stock options vested upon closing of the initial public offering, and the remaining 20% are expected to expire before meeting vesting conditions. Previously, these stock options were incorrectly reported as having an expiration date of the earlier of one year following vesting and 8/3/2031."}],"balance_after":163191,"derivative":{"exercise_price":4.1192,"expiration_date":"2022-01-26","underlying":"Class A common stock","underlying_shares":652764},"source":{"system":"sec-edgar","filing":"0000899243-22-003306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000089924322003306/doc4.xml","form_type":"4"}},{"id":2425322,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A common stock","published_at":"2022-01-26T18:39:45.000Z","date":"2022-01-24","kind":"exercise","acquired":true,"shares":652764,"price":4.1192,"value":2688865.4688,"ownership":{"direct":true},"balance_after":729687,"source":{"system":"sec-edgar","filing":"0000899243-22-003306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000089924322003306/doc4.xml","form_type":"4"}},{"id":2505095,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A common stock","published_at":"2021-11-18T18:00:18.000Z","date":"2021-11-18","kind":"other","acquired":true,"shares":76923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Represents a pro-rata in kind distribution of the Class A common stock held by Bald Eagle IV LLC to one of its members."}],"balance_after":76923,"source":{"system":"sec-edgar","filing":"0000899243-21-045293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000089924321045293/doc4.xml","form_type":"4"}},{"id":2505094,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A common stock","published_at":"2021-11-18T18:00:18.000Z","date":"2021-11-18","kind":"other","acquired":false,"shares":76923,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Bald Eagle IV LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Bald Eagle IV LLC. The Reporting Person is a member of Bald Eagle IV LLC. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of all securities held by Bald Eagle IV LLC in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-045293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000089924321045293/doc4.xml","form_type":"4"}},{"id":2513068,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A preferred stock","published_at":"2021-11-15T18:53:45.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":21511,"ownership":{"direct":false,"nature":"Held by spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by Kristin Diamandis, the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Kristin Diamandis in which the Reporting Person has no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":13824},"source":{"system":"sec-edgar","filing":"0000899243-21-044652","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000089924321044652/doc4.xml","form_type":"4"}},{"id":2513067,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A common stock","published_at":"2021-11-15T18:53:45.000Z","date":"2021-11-15","kind":"purchase","acquired":true,"shares":76923,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Bald Eagle IV LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person beneficially owns 76,923 shares of Class A common stock purchased by Bald Eagle IV LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Bald Eagle IV LLC. The Reporting Person is a member of Bald Eagle IV LLC. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of all securities held by Bald Eagle IV LLC in which the Reporting Person has no pecuniary interest."}],"balance_after":76923,"source":{"system":"sec-edgar","filing":"0000899243-21-044652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000089924321044652/doc4.xml","form_type":"4"}},{"id":2513066,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A common stock","published_at":"2021-11-15T18:53:45.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":271655,"ownership":{"direct":false,"nature":"Held by spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by Kristin Diamandis, the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Kristin Diamandis in which the Reporting Person has no pecuniary interest."}],"balance_after":271655,"source":{"system":"sec-edgar","filing":"0000899243-21-044652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000089924321044652/doc4.xml","form_type":"4"}},{"id":2571770,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-13T18:13:56.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":56053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, September 9, 2021, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":56053,"derivative":{"exercise_price":6.72,"expiration_date":"2031-09-09","underlying":"Class A Common Stock","underlying_shares":56053},"source":{"system":"sec-edgar","filing":"0001213900-21-047754","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000121390021047754/ownership.xml","form_type":"4"}},{"id":2629011,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Compensation Award (Right to Buy)","published_at":"2021-07-20T21:24:04.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":269007,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement and Plan of Merger and Reorganization, dated January 8, 2021 (the \"Business Combination Agreement\"), by and among GX Acquisition Corp. (\"GX\"), Alpha First Merger Sub Corp., Celularity LLC and Celularity Inc. (\"Legacy Celularity\"), each security to purchase shares of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio. Upon consummation of the business combination, GX changed its name to \"Celularity Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Deferred Compensation Award (\"DCA\") shall become exercisable solely upon the first to occur of: (i) the consummation of a change of control that is also a change in the ownership or effective control of the Issuer, or in the ownership of a substantial portion of the Issuer's assets, (ii) the Reporting Person's death or disability, or (iii) March 24, 2023, subject to the Reporting Person's continuous service with the Issuer on such date."}],"balance_after":269007,"derivative":{"exercise_price":3.83,"expiration_date":"2031-07-16","underlying":"Class A Common Stock","underlying_shares":269007},"source":{"system":"sec-edgar","filing":"0001209191-21-047518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000120919121047518/doc4.xml","form_type":"4"}},{"id":2629010,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-20T21:24:04.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":3731136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement and Plan of Merger and Reorganization, dated January 8, 2021 (the \"Business Combination Agreement\"), by and among GX Acquisition Corp. (\"GX\"), Alpha First Merger Sub Corp., Celularity LLC and Celularity Inc. (\"Legacy Celularity\"), each security to purchase shares of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio. Upon consummation of the business combination, GX changed its name to \"Celularity Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable."}],"balance_after":3731136,"derivative":{"exercise_price":0.28,"expiration_date":"2031-07-16","underlying":"Class A Common Stock","underlying_shares":3731136},"source":{"system":"sec-edgar","filing":"0001209191-21-047518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528288/000120919121047518/doc4.xml","form_type":"4"}},{"id":2971441,"issuer":{"id":6455,"kind":"organization","name":"CuriosityStream Inc.","symbol":"CURI"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common Stock","published_at":"2020-11-20T22:23:35.000Z","date":"2020-11-18","kind":"other","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution of shares of common stock, par value $0.0001 per share (\"Common Stock\"), of CuriosityStream Inc. (the \"Company\") from Software Acquisition Holdings, LLC (the \"Sponsor\") to certain of its members. The shares of Common Stock distributed are subject to certain restrictions on transfer."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pro rata distribution of shares of common stock, par value $0.0001 per share (\"Common Stock\"), of CuriosityStream Inc. (the \"Company\") from Software Acquisition Holdings, LLC (the \"Sponsor\") to certain of its members. The shares of Common Stock distributed are subject to certain restrictions on transfer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pro rata distribution of Common Stock from the Sponsor, of which the reporting person is a member."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pro rata distribution of shares of common stock, par value $0.0001 per share (\"Common Stock\"), of CuriosityStream Inc. (the \"Company\") from Software Acquisition Holdings, LLC (the \"Sponsor\") to certain of its members. The shares of Common Stock distributed are subject to certain restrictions on transfer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Pro rata distribution of shares of common stock, par value $0.0001 per share (\"Common Stock\"), of CuriosityStream Inc. (the \"Company\") from Software Acquisition Holdings, LLC (the \"Sponsor\") to certain of its members. The shares of Common Stock distributed are subject to certain restrictions on transfer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Pro rata distribution of Common Stock from the Sponsor, of which the reporting person is a member."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001213900-20-038565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776909/000121390020038565/ownership.xml","form_type":"4"}},{"id":2971440,"issuer":{"id":6455,"kind":"organization","name":"CuriosityStream Inc.","symbol":"CURI"},"owners":[{"id":69323,"kind":"person","name":"Diamandis Peter","position":1,"cik":"0001528288","reported_name":"Diamandis Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common Stock","published_at":"2020-11-20T22:23:35.000Z","date":"2020-11-18","kind":"other","acquired":false,"shares":3737500,"ownership":{"direct":false,"nature":"By the Sponsor"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution of shares of common stock, par value $0.0001 per share (\"Common Stock\"), of CuriosityStream Inc. (the \"Company\") from Software Acquisition Holdings, LLC (the \"Sponsor\") to certain of its members. The shares of Common Stock distributed are subject to certain restrictions on transfer."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pro rata distribution of shares of common stock, par value $0.0001 per share (\"Common Stock\"), of CuriosityStream Inc. (the \"Company\") from Software Acquisition Holdings, LLC (the \"Sponsor\") to certain of its members. The shares of Common Stock distributed are subject to certain restrictions on transfer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pro rata distribution of shares of common stock, par value $0.0001 per share (\"Common Stock\"), of CuriosityStream Inc. (the \"Company\") from Software Acquisition Holdings, LLC (the \"Sponsor\") to certain of its members. The shares of Common Stock distributed are subject to certain restrictions on transfer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Pro rata distribution of shares of common stock, par value $0.0001 per share (\"Common Stock\"), of CuriosityStream Inc. (the \"Company\") from Software Acquisition Holdings, LLC (the \"Sponsor\") to certain of its members. The shares of Common Stock distributed are subject to certain restrictions on transfer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pro rata distribution of Common Stock from the Sponsor, of which the reporting person is a member."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-20-038565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776909/000121390020038565/ownership.xml","form_type":"4"}}]}